| P2093 | author name string | L Wiesmüller | |
| | C Dudenhöffer | |
| | W Deppert | |
| | M Kurth | |
| | F Janus | |
| P2860 | cites work | The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases | Q24319848 |
| | p53 modulation of TFIIH–associated nucleotide excision repair activity | Q24336880 |
| | p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner | Q24643993 |
| | BRCA1 regulates p53-dependent gene expression | Q24685083 |
| | Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 |
| | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
| | Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism | Q28245231 |
| | Oncogenic forms of p53 inhibit p53-regulated gene expression | Q28251120 |
| | p21 is a universal inhibitor of cyclin kinases | Q28257305 |
| | 14-3-3sigma is a p53-regulated inhibitor of G2/M progression | Q28276061 |
| | Association of BRCA1 with Rad51 in mitotic and meiotic cells | Q28302118 |
| | p53 mutations in human cancers | Q28302973 |
| | Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos | Q28510071 |
| | Formation of stable p53 homotetramers and multiples of tetramers | Q44277113 |
| | Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. | Q52528383 |
| | Cell-cycle control and its watchman. | Q53453500 |
| | p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction | Q64386856 |
| | Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 | Q67521108 |
| | An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53 | Q67539546 |
| | A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation | Q71169980 |
| | p53 Protein exhibits 3'-to-5' exonuclease activity | Q71170481 |
| | Human p53 binds Holliday junctions strongly and facilitates their cleavage | Q73119545 |
| | DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53 | Q73615085 |
| | Signaling to p53: breaking the MDM2-p53 circuit | Q77430977 |
| | p53 oligomerization and DNA looping are linked with transcriptional activation | Q28639938 |
| | The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding | Q28639955 |
| | Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 |
| | Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control | Q29616465 |
| | A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53 | Q29618277 |
| | Targeted disruption of the Rad51 gene leads to lethality in embryonic mice | Q29618278 |
| | The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation | Q33846651 |
| | The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis | Q33888765 |
| | Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. | Q33912006 |
| | Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. | Q34055161 |
| | The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity | Q34252975 |
| | Inactivation of p53 results in high rates of homologous recombination | Q34426097 |
| | BRCA1 physically associates with p53 and stimulates its transcriptional activity. | Q34467604 |
| | Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. | Q34741387 |
| | p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. | Q34972350 |
| | p53 function and dysfunction | Q35721291 |
| | A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins | Q36122736 |
| | Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53. | Q36546016 |
| | Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells | Q36647653 |
| | p53 domains: structure, oligomerization, and transformation | Q36662699 |
| | Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing | Q36796242 |
| | Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus | Q38294071 |
| | p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches | Q38294077 |
| | A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein | Q38313694 |
| | Regulation of the specific DNA binding function of p53 | Q38324290 |
| | DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. | Q38345163 |
| | Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding | Q39444904 |
| | Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination | Q39575932 |
| | In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes | Q39873297 |
| | Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids | Q40021667 |
| | The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro | Q40023550 |
| | Wild-type p53 is not a negative regulator of simian virus 40 DNA replication in infected monkey cells. | Q40043948 |
| | Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis | Q40647696 |
| | Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule | Q40665592 |
| | Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. | Q40792701 |
| | p53-catalyzed annealing of complementary single-stranded nucleic acids | Q40873109 |
| | Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells | Q41121209 |
| | Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein | Q41121233 |
| | Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53 | Q42630918 |
| | Specific p53-DNA complexes contain an mdm2-related protein | Q42802655 |
| | Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. | Q43918911 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5773-5784 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Dissociation of the recombination control and the sequence-specific transactivation function of P53 | |
| P478 | volume | 18 | |